@jc403.bsky.social
Reposted
So many settings low dose IL-2 could be beneficial. This is the type of collaborative studies public money should be used for.
January 8, 2026 at 1:09 PM
So many settings low dose IL-2 could be beneficial. This is the type of collaborative studies public money should be used for.
Reposted
After 6 weeks of Rx patients with ACSs, low-dose IL-2 safely increases Tregcell levels and reduces arterial inflammation.
www.nature.com/articles/s41...
www.nature.com/articles/s41...
Anti-inflammatory therapy with low-dose IL-2 in acute coronary syndromes: a randomized phase 2 trial - Nature Medicine
In a randomized phase 2 trial in patients with acute coronary syndrome and high levels of the inflammation biomarker C-reactive protein, treatment with low-dose interleukin-2 increased the numbers of ...
www.nature.com
January 8, 2026 at 11:25 AM
After 6 weeks of Rx patients with ACSs, low-dose IL-2 safely increases Tregcell levels and reduces arterial inflammation.
www.nature.com/articles/s41...
www.nature.com/articles/s41...